Becton Dickinson (NYSE: BDX) introduced today its ultra-fine micro pen needle for use with injection pen devices.
The 6 mm x 32G pen needle is compatible with leading pen injection devices, the company said.
“We added the BD Ultra-Fine micro pen needles to ensure BD has a comprehensive portfolio that provide options to patients and reinforces BD’s commitment to providing the best solutions possible for people with specific preferences while managing their diabetes and striving for the best clinical outcomes,” Nabil Shabshab, worldwide president of BD’s diabetes care & digital health businesses, said in prepared remarks.
“This new needle will help ensure that people with diabetes who prefer a 6mm pen needle will be able to experience the quality and performance of BD Ultra-Fine pen needles.”
People with diabetes often control their blood sugar using daily injections of insulin into the subcutaneous fat of their abdomen, thigh, upper arm or buttocks. But if a needle is too long, diabetic patients run the risk of accidentally injecting their insulin dose into a muscle, BD said.
In last year’s September issue of Mayo Clinic Proceedings, BD helped to co-author an article recommending that patients use the shortest available pen needle for insulin delivery.
See the best minds in medtech live at DeviceTalks Boston on Oct. 2.
